PINCH-1 plays a critical oncogenic role in HNSCC by enhancing DRP1-mediated mitochondrial fission, which may serve as a novel therapeutic target for HNSCC. This evidence concerns the gene LIMS1 and head and neck squamous cell carcinoma.